FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2402511000001101: Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25147701000001117 Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38052601000001110 Madopar 100mg/25mg dispersible tablets (Roche Products Ltd) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Is a Co-beneldopa 25mg/100mg dispersible tablets 100 tablet true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Is pack of Madopar 125 dispersible tablets (Roche Products Ltd) false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has active ingredient Benserazide false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has active ingredient Benserazide hydrochloride false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has AMP Madopar 125 dispersible tablets (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start